|
⚲
|
| Keyboard |
| Unravel Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001876967 |
| Sale | 2026-08-07 (4.5 M Offered, 4.1 M Sold) |
| Fund | |
| Phone | 5109842317 |
| Address | 196 Boston Ave, Suite 1000 Medford, MA 02155 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-24 (D) |
| Exemption | 506(b) |
| Remaining | $400,000 |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Donald Ingber | Director | |
| Frederic Vigneault | Director | |
| Richard Novak | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Amundi Pioneer Institutional Asset Management Inc
✚
|
MA | |
|
Robeco Investment Management Inc
✚
|
MA | |
|
Boston Hill Advisors LLC
✚
|
MA | |
|
Navemar Capital Management LP
✚
|
MA | |
|
Venus Capital Management Inc
✚
|
MA | |
|
Perennial Capital Advisors LLC
✚
|
MA | |
|
Catch Point Rights Partners LP
✚
|
MA | |
|
Boston Partners
✚
|
MA | |
|
Third Rock Ventures LLC
✚
|
MA | |
|
Three BAYS Capital LP
✚
|
MA |